Skip to main content

Home/ Technology/ Group items tagged #biosimilar_trial_result

Rss Feed Group items tagged

jacob logan

ESMO 2019: Samsung Bioepis reveals Bevacizumab biosimilar trial result - 1 views

  •  
    A Phase 3 study comparing Samsung Bioepis' SB8 with Avastin in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) demonstrated equivalent efficacy in terms of risk ratio of overall response rate (ORR).
jacob logan

ESMO 2019: Merck unveils neoadjuvant/adjuvant TNBC trial results - 1 views

  •  
    A regimen of neoadjuvant Keytruda and chemotherapy extended pathological complete response (pCR) rates by 13.6% compared to chemotherapy alone in patients with early triple-negative breast cancer (TNBC), according to findings from the Phase III Keynote-522 study presented at the ESMO Congress 2019.
1 - 2 of 2
Showing 20 items per page